NCT05111561 2026-05-13Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast CancerNational Cancer Institute (NCI)Phase 1 Suspended42 enrolled